請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/68878
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 簡國龍(Kuo-Liong Chien) | |
dc.contributor.author | Yu-Hsuan Lin | en |
dc.contributor.author | 林宇旋 | zh_TW |
dc.date.accessioned | 2021-06-17T02:39:57Z | - |
dc.date.available | 2017-09-13 | |
dc.date.copyright | 2017-09-13 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2017-08-17 | |
dc.identifier.citation | 1. Pearson TA, Mensah GA, Hong Y, Smith SC, Jr. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. Circulation. 2004;110(25):e543-4.
2. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing research reviews. 2011;10(3):319-29. 3. Ramos AM, Pellanda LC, Gus I, Portal VL. Inflammatory markers of cardiovascular disease in the elderly. Arq Bras Cardiol. 2009;92(3):221-8, 7-34. 4. Johnson TE. Recent results: biomarkers of aging. Exp Gerontol. 2006;41(12):1243-6. 5. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Rumley A, Lowe GD, et al. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. J Am Geriatr Soc. 2007;55(5):700-7. 6. Schram MT, Euser SM, de Craen AJ, Witteman JC, Frolich M, Hofman A, et al. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc. 2007;55(5):708-16. 7. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, Jr., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106(5):506-12. 8. Tuomisto K, Jousilahti P, Sundvall J, Pajunen P, Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost. 2006;95(3):511-8. 9. Wassel CL, Barrett-Connor E, Laughlin GA. Association of Circulating C-Reactive Protein and Interleukin-6 with Longevity into the 80s and 90s: The Rancho Bernardo Study. J Clin Endocrinol Metab. 2010. 10. Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation. 2007;116(1):32-8. 11. Hamer M, Chida Y, Stamatakis E. Association of very highly elevated C-reactive protein concentration with cardiovascular events and all-cause mortality. Clin Chem. 2010;56(1):132-5. 12. Koenig W, Lowel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation. 2004;109(11):1349-53. 13. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355(25):2631-9. 14. Pollitt RA, Rose KM, Kaufman JS. Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review. BMC public health. 2005;5:7. 15. Steenland K, Henley J, Calle E, Thun M. Individual- and area-level socioeconomic status variables as predictors of mortality in a cohort of 179,383 persons. Am J Epidemiol. 2004;159(11):1047-56. 16. Steenland K, Hu S, Walker J. All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984-1997. Am J Public Health. 2004;94(6):1037-42. 17. Panagiotakos DB, Pitsavos CE, Chrysohoou CA, Skoumas J, Toutouza M, Belegrinos D, et al. The association between educational status and risk factors related to cardiovascular disease in healthy individuals: The ATTICA study. Ann Epidemiol. 2004;14(3):188-94. 18. Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crimmins EM. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun. 2006;20(5):498-504. 19. Loucks EB, Sullivan LM, Hayes LJ, D'Agostino RB, Sr., Larson MG, Vasan RS, et al. Association of educational level with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2006;163(7):622-8. 20. Maksimovic MZ, Vlajinac HD, Radak DJ, Maksimovic JM, Marinkovic JM, Jorga JB. Association of socioeconomic status measured by education and risk factors for carotid atherosclerosis: cross-sectional study. Croatian medical journal. 2008;49(6):824-31. 21. Steinvil A, Shirom A, Melamed S, Toker S, Justo D, Saar N, et al. Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol. 2008;102(8):1034-9. 22. Loucks EB, Pilote L, Lynch JW, Richard H, Almeida ND, Benjamin EJ, et al. Life course socioeconomic position is associated with inflammatory markers: the Framingham Offspring Study. Soc Sci Med. 2010;71(1):187-95. 23. Kivimaki M, Lawlor DA, Smith GD, Keltikangas-Jarvinen L, Elovainio M, Vahtera J, et al. Early socioeconomic position and blood pressure in childhood and adulthood: the Cardiovascular Risk in Young Finns Study. Hypertension. 2006;47(1):39-44. 24. Tabassum F, Kumari M, Rumley A, Lowe G, Power C, Strachan DP. Effects of socioeconomic position on inflammatory and hemostatic markers: a life-course analysis in the 1958 British birth cohort. Am J Epidemiol. 2008;167(11):1332-41. 25. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(7):483-95. 26. Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J Hypertens. 2003;21(10):1787-803. 27. Yen ML, Yang CY, Yen BL, Ho YL, Cheng WC, Bai CH. Increased high sensitivity C-reactive protein and neutrophil count are related to increased standard cardiovascular risk factors in healthy Chinese men. Int J Cardiol. 2006;110(2):191-8. 28. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002;22(10):1668-73. 29. Iso H, Cui R, Date C, Kikuchi S, Tamakoshi A. C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study. Atherosclerosis. 2009;207(1):291-7. 30. de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le Cessie S, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009;338:a3083. 31. Shishehbor MH, Hazen SL. JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean? Cleveland Clinic journal of medicine. 2009;76(1):37. 32. Galobardes B, Shaw M, Lawlor DA, Lynch JW, Davey Smith G. Indicators of socioeconomic position (part 1). J Epidemiol Community Health. 2006;60(1):7-12. 33. Kivimaki M, Lawlor DA, Juonala M, Smith GD, Elovainio M, Keltikangas-Jarvinen L, et al. Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study. Arterioscler Thromb Vasc Biol. 2005;25(10):2197-202. 34. Goldman N, Glei DA, Lin YH, Weinstein M. Improving Mortality Prediction Using Biosocial Surveys. American Journal of Epidemiology. 2009;169(6):769-79. 35. Cornman JC, Glei DA, Goldman N, Chang MC, Lin HS, Chuang YL, et al. Cohort Profile: The Social Environment and Biomarkers of Aging Study (SEBAS) in Taiwan. Int J Epidemiol. 2014. 36. Goldman N, Lin IF, Weinstein M, Lin YH. Evaluating the quality of self-reports of hypertension and diabetes. Journal of clinical epidemiology. 2003;56(2):148-54. 37. Lu TH, Lee MC, Chou MC. Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol. 2000;29(2):336-43. 38. Glei DA, Goldman N, Lin YH, Weinstein M. Age-related Changes in Biomarkers: Longitudinal Data From a Population-based Sample. Research on Aging. 2011;33(3):312-26. 39. Pencina MJ, D'Agostino RB, Sr., D'Agostino RB, Jr., Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-72; discussion 207-12. 40. Chien KL, Chao CL, Kuo CH, Lin HJ, Liu PH, Chen PR, et al. Plasma fatty acids and the risk of metabolic syndrome in ethnic Chinese adults in Taiwan. Lipids in health and disease. 2011;10:33. 41. Chien KL, Hsu HC, Chen PC, Lin HJ, Su TC, Chen MF, et al. Total 25-hydroxyvitamin D concentration as a predictor for all-cause death and cardiovascular event risk among ethnic Chinese adults: a cohort study in a Taiwan community. PloS one. 2015;10(3):e0123097. 42. Hwang Y-J. The construction and Assessment of the ‘New Occupational Prestige and Socioeconomic Scores for Taiwan’: The Indigenization of the Social Science and Sociology of Education Research. Bulletin of Educational Research. 2003;49(4):1-31. 43. Lu L. Attitudes toward older people and coworkers' intention to work with older employees: A Taiwanese study. The International Journal of Aging and Human Development. 2010;71(4):305-22. 44. Goldman N, Cornman JC, Chang MC. Measuring subjective social status: a case study of older Taiwanese. Journal of cross-cultural gerontology. 2006;21(1-2):71-89. 45. Glei DA, Goldman N, Lin YH, Weinstein M. Age-Related Changes in Biomarkers: Longitudinal Data from a Population-Based Sample. Research on aging. 2011;33(3):312-26. 46. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. Journal of health and social behavior. 1983;24(4):385-96. 47. Nagin DS, Tremblay RE. Analyzing developmental trajectories of distinct but related behaviors: a group-based method. Psychological methods. 2001;6(1):18-34. 48. Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociological Methods & Research. 2007;35(4):542-71. 49. Nagin D. Group-based modeling of development: Harvard University Press; 2005. 50. Lee W-C, Wu Y-C. Characterizing Decision-Analysis Performances of Risk Prediction Models Using ADAPT Curves. Medicine. 2016;95(2). 51. Wu Y-C, Lee W-C. Alternative performance measures for prediction models. PloS one. 2014;9(3):e91249. 52. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol. 2004;159(9):882-90. 53. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499-511. 54. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-40. 55. Shah T, Casas JP, Cooper JA, Tzoulaki I, Sofat R, McCormack V, et al. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol. 2009;38(1):217-31. 56. Abeywardena MY, Leifert WR, Warnes KE, Varghese JN, Head RJ. Cardiovascular biology of interleukin-6. Curr Pharm Des. 2009;15(15):1809-21. 57. Goldman N, Glei DA. Quantifying the value of biomarkers for predicting mortality. Ann Epidemiol. 2015;25(12):901-6 e1-4. 58. Liu C, Armer JM. Education's effect on economic growth in Taiwan. Comparative Education Review. 1993;37(3):304-21. 59. Wang RJ. From elitism to mass higher education in Taiwan: The problems faced. High Educ. 2003;46(3):261-87. 60. Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G. Cumulative life course and adult socioeconomic status and markers of inflammation in adulthood. J Epidemiol Community Health. 2008;62(6):484-91. 61. Jones R, Hardy R, Sattar N, Deanfield JE, Hughes A, Kuh D, et al. Novel coronary heart disease risk factors at 60-64 years and life course socioeconomic position: the 1946 British birth cohort. Atherosclerosis. 2015;238(1):70-6. 62. McDade TW, Hawkley LC, Cacioppo JT. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosomatic medicine. 2006;68(3):376-81. 63. Glymour MM, Clark CR, Patton KK. Socioeconomic Determinants of Cardiovascular Disease: Recent Findings and Future Directions. Current Epidemiology Reports. 2014;1(2):89-97. 64. Petersen KL, Marsland AL, Flory J, Votruba-Drzal E, Muldoon MF, Manuck SB. Community socioeconomic status is associated with circulating interleukin-6 and C-reactive protein. Psychosom Med. 2008;70(6):646-52. 65. Stringhini S, Polidoro S, Sacerdote C, Kelly RS, van Veldhoven K, Agnoli C, et al. Life-course socioeconomic status and DNA methylation of genes regulating inflammation. Int J Epidemiol. 2015;44(4):1320-30. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/68878 | - |
dc.description.abstract | 背景:過去研究發現發炎與老年期健康變化有關,相關證據顯示發炎為動脈硬化之重要致病機轉,並與心血管疾病或全死因死亡風險相關,而C-反應蛋白(CRP)和細胞介白素第六因子(IL-6)為其中較常被探討的兩項發炎指標。相關流行病學研究發現,社會經濟地位高低與發炎指標數值高低呈反向相關,但其與生命歷程社會經濟地位變化之關聯並不明確,又過去此類研究之對象常侷限於西方族群。因此,本研究旨在運用具全台灣代表性之世代追蹤資料,探討:(1)CRP和IL-6兩項發炎指標是否有助改善心血管疾病和全死因死亡風險模型之預測力;(2)幼年至成年及中老年期社會經濟地位變化軌跡,和心血管疾病風險之相關,而其心血管疾病或全死因死亡風險,係以CRP和IL-6兩項發炎因子為測量指標。
材料和方法:分析資料源自具全台代表性之「台灣中老人社會因素與生物指標研究」長期追蹤研究世代,運用Cox迴歸模型估算控制相關危險因子後,相較於最低四分位,CRP或IL-6在其他三個四分位數之心血管疾病或全死因之死亡風險,再以area under the curve of receiver operator characteristics (ROC curve), integrated discrimination improvement (IDI)和net reclassification improvement(NRI)等三項指標,探討將CRP或IL-6加入死亡機率預測模型後,對心血管疾病和全死因死亡預測力之改善情形。另一方面,則以Group-based Trajectory Modeling方法,進行社會經濟地位發展軌跡之分群,再以線性迴歸模型比較不同軌跡群組之發炎因子高低。 結果:本研究針對1,023名於2000年完成收案之54歲以上世代成員追蹤結果,在中位數為11.2年之追蹤期間內,各項死因之死亡人數為351人,其中82人死於心血管疾病。相較於最低四分位,CRP或IL-6之數值較高者,其在追蹤期間之全死因死亡風險較高,相較於CRP值在最低四分位者,CRP值在最高四分位者之相對風險比值為3.64 (95% 信賴區間:2.44-5.44); IL-6 值在最高四分位者相對在最低四分位者之風險比值為2.31 (95%信賴區間:1.62-3.29) 。 IL-6值較高亦與心血管疾病死亡風險顯著相關。兩項發炎指標對全死因和心血管疾病死亡風險預測之改善效果,以IL-6較佳。依發展軌跡分群結果,生命週期社會經濟地位變化分為三群:持續偏低組 (36.5%)、由低轉高組 (26.8%)以及持續居高組 (36.7%)。持續居高組之CRP或IL-6兩項發炎指標數值最低,在調整其他變因後,相較於持續偏低組,由低轉高組之CRP值並無顯著差距 (−0.032 ln mg/L; 95% 信賴區間:−0.193, 0.128),IL-6 值亦無顯著差距(0.017 ln pg/mL; 95%信賴區間:−0.093, 0.128),但持續居高組之CRP數值則顯著較低(−0.279 ln mg/L; 95%信賴區間: −0.434, −0.125) ,IL-6 值亦顯著較低 (−0.129 ln pg/mL; 95%信賴區間:−0.236, −0.023)。 結論:IL-6和CRP皆與全死因死亡風險相關,但IL-6對死亡風險預測之改善效果較佳,兩項指標僅IL-6與心血管病死亡風險具顯著相關。幼年時期居於低社經地位者,在中老年時期之CRP或IL-6數值均較高,而幼年時期居於低社經地位者,即使成年後之社會經濟地位提升,其CRP或IL-6兩項發炎指標數值,仍與持續處於低社會經濟地位者較為接近。 | zh_TW |
dc.description.abstract | Background- Evidence showed that inflammatory response is a key pathway in atherosclerosis and leads to an increased risk of cardiovascular disease (CVD) and all-cause death. Evidence from observational studies suggested that high socioeconomic position (SEP) was inversely associated with the levels of C-reactive protein (CRP) or interleukin-6 (IL-6). However, it is unclear whether the life course SEP affected an association with these biomarker levels. In addition, the data from Asian populations are limited. Therefore, the aims of this study are: (1) to investigate the added values of CRP and IL-6 in predicting cardiovascular mortality and all-cause mortality among a representative adult cohort in Taiwan; and (2) to examine how life course trajectory of SEP predicted the risk of cardiovascular disease and all-cause mortality measured with CRP and IL-6.
Material and Methods- We applied data from the Social Environment and Biomarkers of Aging Study (SEBAS), which was a prospective, population-based study of a national representative cohort in Taiwan. First, we used a Cox regression to estimate adjusted relative risks for of the roles of CRP and IL-6. Second, three indicators were applied to investigate the additive value of IL-6 and CRP to the Framingham risk score and lifestyle factors in predicting all-cause and cardiovascular mortality, including area under the curve of receiver operator characteristics curve, integrated discrimination improvement (IDI), and net reclassification improvement (NRI). Finally, we applied group-based trajectory modeling to determine life course trajectory groups or SEP; then use multivariable linear regressions to compare level of CRP and IL-6 among individuals in different trajectory groups. Results- Among the population-representative sample of 1,023 adults aged 54 and above in Taiwan, a total of 351 deaths and 82 cardiovascular deaths were identified after a median follow-up of 11.2 years. After adjustment for established risk factors, elevated IL-6 and CRP were associated with a higher risk of all-cause death: the hazard ratio for the highest risk quartile compared with the lowest quartile was 3.64 [95% confidence interval (CI), 2.44-5.44] for IL-6 and 2.31 (95% CI, 1.62-3.29) for CRP. IL-6 was also significantly associated with cardiovascular mortality. For both all-cause and cardiovascular mortality, IL-6 yielded a substantial increase in the area under the receiver operator characteristic curve (ΔAUC=0.036 and 0.024, respectively), but CRP did not (ΔAUC=0.004 and 0.009, respectively). Three trajectories of life-course SEP were identified within the total sample: Low-Low (36.5%), Low-High (26.8%), and High-High (36.7%). Participants in the High-High group had the lowest levels of CRP and IL-6. Compared with those in the Low-Low group, the participants in the Low-High group had a similar adjusted CRP (−0.032 ln mg/L; 95% CI, −0.193, 0.128) and IL-6 (0.017 ln pg/mL; 95% CI, −0.093, 0.128); the participants in the High-High group had a significantly lower level of adjusted CRP concentration (−0.279 ln mg/L; 95% CI, −0.434, −0.125) and similarly lower IL-6 concentration (−0.129 ln pg/mL; 95% CI, −0.236, −0.023) . Conclusion- IL-6 and CRP were both significantly associated with all-cause mortality; however, only IL-6 provided a substantial improvement in discrimination. IL-6 demonstrated notable prognostic value for predicting cardiovascular mortality, but not CRP. Low SEP in childhood is related to elevated inflammatory markers in older age. Even after the transition from low SEP in childhood to high SEP in older age, the risk remains. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T02:39:57Z (GMT). No. of bitstreams: 1 ntu-106-D96846002-1.pdf: 11101500 bytes, checksum: 00750e80ab674e9f8c13cc1dc1725454 (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | 論文口試委員審定書 I
誌 謝 II 中文摘要 III Abstract V Abbreviation List VIII Table of Content IX Chapter 1. Introduction 1 Chapter 2. Objectives 12 Chapters 3. Materials and Methods 13 Chapter 4 Results 34 Chapter 5 Discussion 40 Reference 56 Table 65 Figure 76 Appendix 85 | |
dc.language.iso | en | |
dc.title | 社會經濟地位與發炎指標及心臟血管疾病與全死因死亡風險-臺灣代表性世代追蹤研究資料分析 | zh_TW |
dc.title | Association of Socioeconomic Position with Inflammation Biomarkers and the Risk of Cardiovascular and All-cause Death among a Representative Cohort in Taiwan | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 季瑋珠(Wei-Chu Chie),李文宗(Wen-Chung Lee),鄭雅文(Yawen Cheng),孫建安(Chien-An Sun),洪百薰(Baai-Shyun Hurng) | |
dc.subject.keyword | 社會經濟地位,C-反應蛋白,細胞介白素第六因子,心血管疾病,死亡率,生命週期, | zh_TW |
dc.subject.keyword | socioeconomic position,cardiovascular disease,C-reactive protein,interleukin-6,inflammation,mortality,life course, | en |
dc.relation.page | 95 | |
dc.identifier.doi | 10.6342/NTU201703662 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2017-08-17 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-1.pdf 目前未授權公開取用 | 10.84 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。